Optimer Pharmaceuticals Explores Collaborative Opportunities With C&O Pharmaceutical Technology

Optimer Pharmaceuticals, Inc. and C&O Pharmaceutical Technology (Holdings) Limited announced that they have signed a non-binding Memorandum of Understanding (MOU) for the exploration of potential business collaborations in the U.S. and China.
Optimer